Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1966 Nov;45(11):1732–1740. doi: 10.1172/JCI105479

Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

E M Tan, P H Schur, R I Carr, H G Kunkel
PMCID: PMC292857  PMID: 4959277

Full text

PDF
1735

Images in this article

1733Image
on p.1733
1734Image
on p.1734
1734Image
on p.1734
1736Image
on p.1736

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON J. R., GRAY K. G., BECK J. S., BUCHANAN W. W., McELHINNEY A. J. Precipitating auto-antibodies in the connective tissue diseases. Ann Rheum Dis. 1962 Dec;21:360–369. doi: 10.1136/ard.21.4.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AYALA W., MOORE L. V., HESS E. L. The purple color reaction given by diphenylamine reagent. I. With normal and rheumatic fever sera. J Clin Invest. 1951 Jul;30(7):781–785. doi: 10.1172/JCI102492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BENDICH A., WILCZOK T., BORENFREUND E. CIRCULATING DNA AS A POSSIBLE FACTOR IN ONCOGENESIS. Science. 1965 Apr 16;148(3668):374–376. doi: 10.1126/science.148.3668.374. [DOI] [PubMed] [Google Scholar]
  4. BUTLER V. P., Jr, BEISER S. M., ERLANGER B. F., TANENBAUM S. W., COHEN S., BENDICH A. Purine-specific antibodies which react with deoxvribonucleic acid (DNA). Proc Natl Acad Sci U S A. 1962 Sep 15;48:1597–1602. doi: 10.1073/pnas.48.9.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barnett E. V., Vaughan J. H. Antinuclear antibodies in rabbit antisera. J Exp Med. 1966 Apr 1;123(4):733–746. doi: 10.1084/jem.123.4.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CASALS S. P., FRIOU G. J., MYERS L. L. SIGNIFICANCE OF ANTIBODY TO DNA IN SYSTEMIC LUPUS ERYTHEMATOSUS. Arthritis Rheum. 1964 Aug;7:379–390. doi: 10.1002/art.1780070404. [DOI] [PubMed] [Google Scholar]
  7. CEPPELLINI R., POLLI E., CELADA F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med. 1957 Dec;96(3):572–574. doi: 10.3181/00379727-96-23544. [DOI] [PubMed] [Google Scholar]
  8. CHRISTIAN C. L., DESIMONE A. R., ABRUZZO J. L. ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS. J Exp Med. 1965 Feb 1;121:309–321. doi: 10.1084/jem.121.2.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. FREEDMAN P., MARKOWITZ A. S. Gamma globulin and complement in the diseased kidney. J Clin Invest. 1962 Feb;41:328–334. doi: 10.1172/JCI104486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GERMUTH F. G., Jr, MCKINNON G. E. Studies on the biological properties of antigen-antibody complexes. I. Anaphylatic shock induced by soluble antigen-antibody complexes in unsensitized normal guinea pigs. Bull Johns Hopkins Hosp. 1957 Jul;101(1):13–44. [PubMed] [Google Scholar]
  12. GUPTA S., HERRIOTT R. M. Nucleases and their inhibitors in the cellular components of human blood. Arch Biochem Biophys. 1963 Apr;101:88–95. doi: 10.1016/0003-9861(63)90538-1. [DOI] [PubMed] [Google Scholar]
  13. HERRIOTT R. M., CONNOLLY J. H., GUPTA S. Blood nucleases and infectious viral nucleic acids. Nature. 1961 Mar 11;189:817–820. doi: 10.1038/189817a0. [DOI] [PubMed] [Google Scholar]
  14. HOLMAN H. R., DEICHER H. R., KUNKEL H. G. The L. E. cell and the L. E. serum factors. Bull N Y Acad Med. 1959 Jul;35(7):409–418. [PMC free article] [PubMed] [Google Scholar]
  15. KURNICK N. B. Desoxyribonuclease activity of sera of man and some other species. Arch Biochem Biophys. 1953 Mar;43(1):97–107. doi: 10.1016/0003-9861(53)90088-5. [DOI] [PubMed] [Google Scholar]
  16. LEE J. B. COMPOUNDS INTERFERING IN THE DIPHENYLAMINE TEST FOR DEOXYRIBONUCLEIC ACID. Nature. 1963 Oct 19;200:264–266. doi: 10.1038/200264a0. [DOI] [PubMed] [Google Scholar]
  17. MASTER R. W. POSSIBLE SYNTHESIS OF POLYRIBONUCLEOTIDES OF KNOWN BASE-TRIPLET SEQUENCES. Nature. 1965 Apr 3;206:93–93. doi: 10.1038/206093b0. [DOI] [PubMed] [Google Scholar]
  18. MIESCHER P., STRASSLE R. New serological methods for the detection of the L.E. factor. Vox Sang. 1957 Sep;2(4):283–287. doi: 10.1111/j.1423-0410.1957.tb03704.x. [DOI] [PubMed] [Google Scholar]
  19. McCARTY M. The inhibition of streptococcal desoxyribonuclease by rabbit and human antisera. J Exp Med. 1949 Dec;90(6):543–553. doi: 10.1084/jem.90.6.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PLESCIA O. J., BRAUN W., PALCZUK N. C. PRODUCTION OF ANTIBODIES TO DENATURED DEOXYRIBONUCLEIC ACID (DNA). Proc Natl Acad Sci U S A. 1964 Aug;52:279–285. doi: 10.1073/pnas.52.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. ROBBINS W. C., HOLMAN H. R., DEICHER H., KUNKEL H. G. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med. 1957 Dec;96(3):575–579. doi: 10.3181/00379727-96-23545. [DOI] [PubMed] [Google Scholar]
  22. SELA M., UNGAR-WARON H., SHECHTER Y. URIDINE-SPECIFIC ANTIBODIES OBTAINED WITH SYNTHETIC ANTIGENS. Proc Natl Acad Sci U S A. 1964 Aug;52:285–292. doi: 10.1073/pnas.52.2.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. SELIGMANN M., MILGROM F. Mise en évidence par la fixation du complément de la réaction entre acide désoxyribonucléique et sérum de malades atteints de lupus érythémateux disséminé. C R Hebd Seances Acad Sci. 1957 Oct 21;245(17):1472–1475. [PubMed] [Google Scholar]
  24. SELIGMANN M. Mise en évidence dans le sérum de malades atteints de lupus erythémateux disséminé d'une substance déterminant une réaction de précipitation avec l'acide désoxyribonucléique. C R Hebd Seances Acad Sci. 1957 Jul 8;245(2):243–245. [PubMed] [Google Scholar]
  25. STOLLAR D., LEVINE L., LEHRER H. I., VAN VUNAKIS H. The antigenic determinants of denatured DNA reactive with lupus erythematosus serum. Proc Natl Acad Sci U S A. 1962 May 15;48:874–880. doi: 10.1073/pnas.48.5.874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tan E. M., Kunkel H. G. An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum. 1966 Feb;9(1):37–46. doi: 10.1002/art.1780090105. [DOI] [PubMed] [Google Scholar]
  27. Tan E. M., Kunkel H. G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol. 1966 Mar;96(3):464–471. [PubMed] [Google Scholar]
  28. Tanenbaum S. W., Beiser S. M. PYRIMIDINE-SPECIFIC ANTIBODIES WHICH REACT WITH DEOXYRIBONUCLEIC ACID (DNA). Proc Natl Acad Sci U S A. 1963 May;49(5):662–668. doi: 10.1073/pnas.49.5.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WARD P. A., COCHRANE C. G. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS. J Exp Med. 1965 Feb 1;121:215–234. doi: 10.1084/jem.121.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. WASSERMAN E., LEVINE L. Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition. J Immunol. 1961 Sep;87:290–295. [PubMed] [Google Scholar]
  31. WROBLEWSKI F., BODANSKY O. Presence of desoxyribonuclease activity in human serum. Proc Soc Exp Biol Med. 1950 Jun;74(2):443–445. doi: 10.3181/00379727-74-17933. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES